↓ Skip to main content

Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering

Overview of attention for article published in Frontiers in Genetics, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
6 X users
patent
17 patents
peer_reviews
1 peer review site

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering
Published in
Frontiers in Genetics, January 2012
DOI 10.3389/fgene.2012.00154
Pubmed ID
Authors

Jesper B. Bramsen, Jørgen Kjems

Abstract

Recent successes in clinical trials have provided important proof of concept that small interfering RNAs (siRNAs) indeed constitute a new promising class of therapeutics. Although great efforts are still needed to ensure efficient means of delivery in vivo, the siRNA molecule itself has been successfully engineered by chemical modification to meet initial challenges regarding specificity, stability, and immunogenicity. To date, a great wealth of siRNA architectures and types of chemical modification are available for promoting safe siRNA-mediated gene silencing in vivo and, consequently, the choice of design and modification types can be challenging to individual experimenters. Here we review the literature and devise how to improve siRNA performance by structural design and specific chemical modification to ensure potent and specific gene silencing without unwarranted side-effects and hereby complement the ongoing efforts to improve cell targeting and delivery by other carrier molecules.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 2%
Spain 1 <1%
Unknown 108 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 27 24%
Researcher 15 14%
Student > Bachelor 15 14%
Student > Master 14 13%
Other 8 7%
Other 11 10%
Unknown 21 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 25%
Agricultural and Biological Sciences 25 23%
Chemistry 10 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Medicine and Dentistry 7 6%
Other 12 11%
Unknown 21 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2024.
All research outputs
#2,700,752
of 26,267,662 outputs
Outputs from Frontiers in Genetics
#639
of 13,881 outputs
Outputs of similar age
#19,212
of 253,899 outputs
Outputs of similar age from Frontiers in Genetics
#18
of 253 outputs
Altmetric has tracked 26,267,662 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,881 research outputs from this source. They receive a mean Attention Score of 3.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,899 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.